IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy
Masataka Taoka,1 Nobuaki Ochi,1 Ayaka Mimura,1 Naruhiko Ichiyama,1 Yasunari Nagasaki,1 Nozomu Nakagawa,1 Hidekazu Nakanishi,1 Hiromichi Yamane,1 Yoshiyuki Oshiro,2 Yasumasa Monobe,3 Nagio Takigawa1 1Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan; 2Department of Ge...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-06-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/iga-vasculitis-in-a-lung-cancer-patient-during-chemoradiotherapy-peer-reviewed-fulltext-article-TCRM |
id |
doaj-62711fd7418d4fcfabfc363cd2389cd8 |
---|---|
record_format |
Article |
spelling |
doaj-62711fd7418d4fcfabfc363cd2389cd82021-06-08T19:41:46ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2021-06-01Volume 1757157565494IgA Vasculitis in a Lung Cancer Patient During ChemoradiotherapyTaoka MOchi NMimura AIchiyama NNagasaki YNakagawa NNakanishi HYamane HOshiro YMonobe YTakigawa NMasataka Taoka,1 Nobuaki Ochi,1 Ayaka Mimura,1 Naruhiko Ichiyama,1 Yasunari Nagasaki,1 Nozomu Nakagawa,1 Hidekazu Nakanishi,1 Hiromichi Yamane,1 Yoshiyuki Oshiro,2 Yasumasa Monobe,3 Nagio Takigawa1 1Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan; 2Department of General Internal Medicine 3, Kawasaki Medical School, Okayama, Japan; 3Department of Pathology, Kawasaki Medical School, Okayama, JapanCorrespondence: Nobuaki OchiDepartment of General Internal Medicine 4, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama, JapanTel +81-86-225-2111Email placidus.aura@gmail.comAbstract: A 72-year-old man with locally advanced lung squamous cell carcinoma experienced red purpura on the lower legs and hematuria when the disease progressed during definitive chemoradiotherapy. He had renal dysfunction and proteinuria. Biopsy specimens of the skin lesion and kidney revealed immunoglobulin A vasculitis. Potential causes such as paraneoplastic syndrome and cancer treatment have been proposed. The administration of steroids rapidly improved the symptoms. The presentation of immunoglobulin A vasculitis is accompanied by malignancies. Clinicians should keep this syndrome in mind, even during curative-intent treatment.Keywords: IgA vasculitis, lung cancer, squamous cell carcinoma, nephritis, paraneoplastic syndromehttps://www.dovepress.com/iga-vasculitis-in-a-lung-cancer-patient-during-chemoradiotherapy-peer-reviewed-fulltext-article-TCRMiga vasculitislung cancersquamous cell carcinomanephritisparaneoplastic syndrome |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Taoka M Ochi N Mimura A Ichiyama N Nagasaki Y Nakagawa N Nakanishi H Yamane H Oshiro Y Monobe Y Takigawa N |
spellingShingle |
Taoka M Ochi N Mimura A Ichiyama N Nagasaki Y Nakagawa N Nakanishi H Yamane H Oshiro Y Monobe Y Takigawa N IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy Therapeutics and Clinical Risk Management iga vasculitis lung cancer squamous cell carcinoma nephritis paraneoplastic syndrome |
author_facet |
Taoka M Ochi N Mimura A Ichiyama N Nagasaki Y Nakagawa N Nakanishi H Yamane H Oshiro Y Monobe Y Takigawa N |
author_sort |
Taoka M |
title |
IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy |
title_short |
IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy |
title_full |
IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy |
title_fullStr |
IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy |
title_full_unstemmed |
IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy |
title_sort |
iga vasculitis in a lung cancer patient during chemoradiotherapy |
publisher |
Dove Medical Press |
series |
Therapeutics and Clinical Risk Management |
issn |
1178-203X |
publishDate |
2021-06-01 |
description |
Masataka Taoka,1 Nobuaki Ochi,1 Ayaka Mimura,1 Naruhiko Ichiyama,1 Yasunari Nagasaki,1 Nozomu Nakagawa,1 Hidekazu Nakanishi,1 Hiromichi Yamane,1 Yoshiyuki Oshiro,2 Yasumasa Monobe,3 Nagio Takigawa1 1Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan; 2Department of General Internal Medicine 3, Kawasaki Medical School, Okayama, Japan; 3Department of Pathology, Kawasaki Medical School, Okayama, JapanCorrespondence: Nobuaki OchiDepartment of General Internal Medicine 4, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama, JapanTel +81-86-225-2111Email placidus.aura@gmail.comAbstract: A 72-year-old man with locally advanced lung squamous cell carcinoma experienced red purpura on the lower legs and hematuria when the disease progressed during definitive chemoradiotherapy. He had renal dysfunction and proteinuria. Biopsy specimens of the skin lesion and kidney revealed immunoglobulin A vasculitis. Potential causes such as paraneoplastic syndrome and cancer treatment have been proposed. The administration of steroids rapidly improved the symptoms. The presentation of immunoglobulin A vasculitis is accompanied by malignancies. Clinicians should keep this syndrome in mind, even during curative-intent treatment.Keywords: IgA vasculitis, lung cancer, squamous cell carcinoma, nephritis, paraneoplastic syndrome |
topic |
iga vasculitis lung cancer squamous cell carcinoma nephritis paraneoplastic syndrome |
url |
https://www.dovepress.com/iga-vasculitis-in-a-lung-cancer-patient-during-chemoradiotherapy-peer-reviewed-fulltext-article-TCRM |
work_keys_str_mv |
AT taokam igavasculitisinalungcancerpatientduringchemoradiotherapy AT ochin igavasculitisinalungcancerpatientduringchemoradiotherapy AT mimuraa igavasculitisinalungcancerpatientduringchemoradiotherapy AT ichiyaman igavasculitisinalungcancerpatientduringchemoradiotherapy AT nagasakiy igavasculitisinalungcancerpatientduringchemoradiotherapy AT nakagawan igavasculitisinalungcancerpatientduringchemoradiotherapy AT nakanishih igavasculitisinalungcancerpatientduringchemoradiotherapy AT yamaneh igavasculitisinalungcancerpatientduringchemoradiotherapy AT oshiroy igavasculitisinalungcancerpatientduringchemoradiotherapy AT monobey igavasculitisinalungcancerpatientduringchemoradiotherapy AT takigawan igavasculitisinalungcancerpatientduringchemoradiotherapy |
_version_ |
1721389499483684864 |